Actively Recruiting
Study of Targeted Radiation and Timing of Hormone Therapy in Men with Recurrent Metastatic Hormone-Sensitive Prostate Cancer
Led by Mayo Clinic · Updated on 2026-07-20
532
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating treatment options for men with hormone-sensitive prostate cancer that has spread to other parts of the body and returned after improvement. This phase II trial compares the effects of stereotactic body radiation therapy SBRT combined with androgen receptor pathway inhibitors ARPI and androgen deprivation therapy ADT versus SBRT alone with watchful waiting. The study also examines salvage radiation therapy sXRT to the prostate and whether pelvic radiation helps prevent further cancer spread. Participants are assigned to one of two cohorts and randomized into groups that receive different treatments. One cohort compares SBRT with ARPI plus ADT followed by watchful waiting to SBRT with watchful waiting alone. The other cohort compares sXRT with watchful waiting to initial observation with later image-guided therapy if needed. Treatments are given in cycles repeating every 4 months for up to 6 months or until disease progression or unacceptable side effects. Throughout the trial, participants undergo blood collection and imaging scans such as PET, CT, MRI, or bone scans. During the study, participants will be monitored for up to 5 years to assess cancer progression and survival. Researchers will evaluate modified radiographic progression-free survival, distant progression-free survival, overall survival, and biochemical progression-free survival. Safety is monitored using standardized criteria, and blood and tissue samples are collected for research on disease markers. Follow-up visits occur every 6 months after treatment completion to continue monitoring participants health.
CONDITIONS
Brief Title
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Research Team
C
Clinical Trials Referral Office
C
Cancer Center Clinical Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here